Cabaletta Bio

Forecast & Rating10 analysts currently cover Cabaletta Bio, with about 80.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $13.25, about 430.0% upside from the current price of $2.50. Price targets range from $3.00 to $30.00 — a wide spread, showing clear disagreement over just how much Cabaletta Bio can rise. Historically, about 41.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Cabaletta Bio closely still see room for the stock to rise. Data as of Sep 11, 2026; for reference only and not investment advice.